Heska Corporation (HSKA) Stock Price, Forecast & Analysis
USA - NASDAQ:HSKA - US42805E3062 - Common Stock
HSKA Key Statistics, Chart & Performance
The current stock price of HSKA is 119.99 USD. In the past month the price increased by 2.45%. In the past year, price increased by 42.46%.
HSKA Latest News, Press Relases and Analysis
HSKA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.9 | 224.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.68 | 202.72B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.59 | 155.55B | ||
| SYK | STRYKER CORP | 28.35 | 142.76B | ||
| IDXX | IDEXX LABORATORIES INC | 55.63 | 56.12B | ||
| BDX | BECTON DICKINSON AND CO | 13.39 | 55.33B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.51 | 50.56B | ||
| RMD | RESMED INC | 25.47 | 36.79B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.12 | 33.77B | ||
| DXCM | DEXCOM INC | 32.11 | 23.42B | ||
| PODD | INSULET CORP | 72.79 | 23.42B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.2 | 17.94B |
Related stock screener links
About HSKA
Company Profile
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
Company Info
Heska Corporation
3760 Rocky Mountain Ave
Loveland COLORADO 80538 US
CEO: Kevin S. Wilson
Employees: 808
Phone: 19704937272.0
Heska Corporation / HSKA FAQ
Can you describe the business of Heska Corporation?
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
What is the current price of HSKA stock?
The current stock price of HSKA is 119.99 USD. The price increased by 0.04% in the last trading session.
Does Heska Corporation pay dividends?
HSKA does not pay a dividend.
What is the ChartMill rating of Heska Corporation stock?
HSKA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting HSKA stock to perform?
10 analysts have analysed HSKA and the average price target is 132.6 USD. This implies a price increase of 10.51% is expected in the next year compared to the current price of 119.99.
What is Heska Corporation worth?
Heska Corporation (HSKA) has a market capitalization of 1.31B USD. This makes HSKA a Small Cap stock.
HSKA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to HSKA. When comparing the yearly performance of all stocks, HSKA is one of the better performing stocks in the market, outperforming 93.8% of all stocks.
HSKA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HSKA. While HSKA has a great health rating, there are worries on its profitability.
HSKA Financial Highlights
Over the last trailing twelve months HSKA reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -51.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.23 |
HSKA Forecast & Estimates
10 analysts have analysed HSKA and the average price target is 132.6 USD. This implies a price increase of 10.51% is expected in the next year compared to the current price of 119.99.
For the next year, analysts expect an EPS growth of 55.25% and a revenue growth 9.92% for HSKA